dalteparin and zithromax

dalteparin has been researched along with zithromax in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's9 (90.00)2.80

Authors

AuthorsStudies
Bateman, KA; Dean, NC; Donnelly, SM; Hale, D; Silver, MP; Snow, GL1
Bartoletti, M; Viale, P1
Fueyo-Rodriguez, O; Moreno-Sanchez, F; Palomar-Lever, A; Valente-Acosta, B1
Cipriani, MS; Massabeti, R; Valenti, I1
Altunok, ES; Cengel, F; Ekin, EE; Gurkan, O; Yilmaz, A1
Ahuka-Mundeke, S; Bongo-Pasi Nswe, C; Hermans, MP; Ishoso, DK; Kayembe, JM; KoliƩ, MC; Machekano, RN; Madinga, JN; Mavungu Landu, DJ; Mbala-Kingebeni, P; Mbuyi, GM; Mellors, JW; Mills, EJ; Mofenson, L; Mukeba Tshialala, D; Mukendi, S; Muyembe-Tamfum, JJ; Nachega, JB; Nkwembe, EN; Nsio, JM; Otokoye, JO; Sam-Agudu, NA; Smith, G; Tshiasuma Pipo, M; Zumla, A1
Akat, H; Laloglu, F; Orbak, Z1
Berns, SA; Ershov, FI; Myasnikov, AL; Talyzin, PA1
Ahmed, WU; Alghoul, H; Alser, O; Alshammari, TM; Areia, C; Burn, E; Carter, W; Casajust, P; Cho, J; Dawoud, D; Duarte-Salles, T; Golozar, A; Gong, M; Hripcsak, G; Jonnagaddala, J; Kostka, K; Lai, LYH; Lane, JC; Liu, L; Lynch, KE; Matheny, ME; Mehta, PP; Morales, DR; Nyberg, F; Posada, JD; Prats-Uribe, A; Prieto-Alhambra, D; Recalde, M; Reich, C; Rijnbeek, PR; Roel, E; Ryan, PB; Schilling, LM; Sena, AG; Shah, K; Shah, NH; Subbian, V; Suchard, MA; Vizcaya, D; You, SC; Zhang, L; Zhang, Y; Zhu, H1
Alkan, M; Demirkol, MA; Dinc, V; Esatoglu, SN; Kamat, S; Kostek, ME; Sargin Altunok, E; Satici, C; Toprak, ID; Yazla, S1

Trials

1 trial(s) available for dalteparin and zithromax

ArticleYear
[Interferon gamma in the treatment of patients with moderate COVID-19].
    Voprosy virusologii, 2021, 03-07, Volume: 66, Issue:1

    Topics: Aged; Ampicillin; Anti-Infective Agents; Anticoagulants; Azithromycin; Blood Pressure; COVID-19; COVID-19 Drug Treatment; Enoxaparin; Female; Humans; Hydroxychloroquine; Immunologic Factors; Interferon-gamma; Male; Middle Aged; Random Allocation; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Vancomycin

2021

Other Studies

9 other study(ies) available for dalteparin and zithromax

ArticleYear
Improved clinical outcomes with utilization of a community-acquired pneumonia guideline.
    Chest, 2006, Volume: 130, Issue:3

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Azithromycin; Community-Acquired Infections; Enoxaparin; Female; Guideline Adherence; Hospitalization; Humans; Length of Stay; Male; Medicaid; Medicare; Patient Readmission; Pneumonia, Bacterial; Practice Guidelines as Topic; Survival Rate; Treatment Outcome; Utah

2006
Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin.
    Le infezioni in medicina, 2020, Jun-01, Volume: 28, Issue:suppl 1

    Topics: Aged; Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Azithromycin; Combined Modality Therapy; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Enoxaparin; Humans; Hydroxychloroquine; Hypertension; Male; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Thrombophilia; Tomography, X-Ray Computed; Valsartan

2020
Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
    BMJ case reports, 2020, Jun-24, Volume: 13, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Anticoagulants; Azithromycin; Betacoronavirus; Bicarbonates; Ceftriaxone; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A Inhibitors; Enoxaparin; Enzyme Inhibitors; Fluid Therapy; Humans; Hydroxychloroquine; Lopinavir; Lung; Male; Pandemics; Pneumonia, Viral; Respiration, Artificial; Rhabdomyolysis; Ritonavir; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome

2020
Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
    Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2020, Jul-03, Volume: 27, Issue:S Pt 1

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Azithromycin; China; Coronavirus Infections; COVID-19; Darunavir; Disease Progression; Enoxaparin; Humans; Hydroxychloroquine; Male; Middle Aged; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Ritonavir

2020
COVID-19 Pulmonary Infection with Pneumothorax in a Young Patient.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2020, Volume: 30, Issue:6

    Topics: Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Betacoronavirus; Coronavirus; Coronavirus Infections; Cough; COVID-19; Enoxaparin; Female; Fever; Humans; Hydroxychloroquine; Lung; Male; Oseltamivir; Pandemics; Pneumonia, Viral; Pneumothorax; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2020
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:6

    Topics: Adolescent; Adult; Asymptomatic Diseases; Azithromycin; Chloroquine; COVID-19; COVID-19 Drug Treatment; Democratic Republic of the Congo; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Hospitals; Humans; Intensive Care Units; Lopinavir; Male; Middle Aged; Obesity; Pandemics; Patient Discharge; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome

2020
Effectiveness of lopinavir/ritonavir on COVID-19-related pneumonia in a child with COVID-19-associated Kawasaki disease.
    Cardiology in the young, 2021, Volume: 31, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; Anticoagulants; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Drug Combinations; Enoxaparin; Humans; Hydroxychloroquine; Hypoxia; Immunoglobulins, Intravenous; Immunologic Factors; Lopinavir; Lung; Male; Mucocutaneous Lymph Node Syndrome; Oseltamivir; Oxygen Inhalation Therapy; Ritonavir; Sulbactam; Tomography, X-Ray Computed

2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
    BMJ (Clinical research ed.), 2021, 05-11, Volume: 373

    Topics: Administrative Claims, Healthcare; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Azithromycin; Ceftriaxone; Chemotherapy, Adjuvant; Child; Child, Preschool; China; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Repositioning; Electronic Health Records; Enoxaparin; Female; Fluoroquinolones; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Inpatients; Lopinavir; Male; Middle Aged; Republic of Korea; Ritonavir; Safety; SARS-CoV-2; Spain; Treatment Outcome; United States; Vitamin D; Young Adult

2021
Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.
    Journal of medical virology, 2022, Volume: 94, Issue:1

    Topics: Aged; Amides; Antibodies, Monoclonal, Humanized; Azithromycin; C-Reactive Protein; Comorbidity; COVID-19; COVID-19 Drug Treatment; Critical Care; Drug Combinations; Enoxaparin; Female; Hospital Mortality; Hospitalization; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Male; Methylprednisolone; Middle Aged; Pyrazines; Retrospective Studies; Ritonavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Turkey

2022